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Background: Whether concentric left ventricular (LV) hypertrophy (LVH) in heart failure with preserved ejection fraction (HFPEF) is associated with 
increased risk of adverse cardiovascular events is not well studied. We hypothesized that concentric LVH carry increased risk of 1-year mortality and 
rehospitalization.
Methods: Prospective longitudinal single-centre study of 199 consecutive patients hospitalized for HFPEF. Echocardiography was performed, and LV 
mass index (LVMi) and relative wall thickness (RWT) were calculated, and patients stratified into groups: normal geometry (A), concentric remodeling 
(B), eccentric LVH (C) and concentric LVH (D). Primary outcome was assessed by hierarchical censoring of death, following by rehospitalization 
events.
Results: (see table). Median LVMi and RWT were 113 g/m2 and 0.44. At 1 year, 71 patients had outcome events (28 deaths, 43 
rehospitalizations). Relative to group A, 1-year mortality after adjusting for baseline covariates, significantly increased in groups B to D, with 
respective hazard ratios [HR] (95%CI): 3.30 (0.37 - 29.49); 3.02 (0.34 - 27.04); and 7.75 (1.02-58.94).Multivariable logistic regression identified 
concentric LVH adjusting for clinical and other parameters, as the most consistent predictor of both 1-year mortality (odds ratio [OR] (95%CI): 2.46 
(1.08, 5.61), p=0.033) and rehospitalization (2.64 (1.30, 5.34), p=0.007).
Conclusions: In HFPEF, concentric LVH confers high risk for 1-year mortality and rehospitalization. 
Baseline clinical and echocardiographic characteristics
Variable Concentric LVH (n=61) Without concentric LVH (n=138) p value
Age (years) 75 (68, 81) 74 (66, 80) 0.184
Female %(n) 64% (39) 55% (76) 0.243
Diabetes %(n) 23% (14) 23% (31) 0.94
Hypertension %(n) 80% (49) 75%(104) 0.444
Prior MI %(n) 18% (11) 13%(18) 0.358
Creatinine (umol/L) 113 (89, 155) 92 (74, 129) 0.011
Serum Sodium (mmol/L) 138 (136, 140) 138 (135, 140) 0.151
Relative wall thickness 0.51 (0.46, 0.62) 0.40 (0.35, 0.48) 0.0001
LV mass index (g/m2) 137 (121, 163) 96 (81, 126) 0.0001
